In ₹ Crore except Per Share Latest Annual | CONCORDBIO FY26 | BIOCON FY26 | DIVISLAB FY26 | CAPLIPOINT FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 58.32× | 138.65× | 97.31× | ◆ 33.10× | 97.31× -40% | |
| P/B | 7.50× | ◆ 1.73× | 14.89× | 5.84× | 5.84× +28% | |
| EV/EBITDA | 40.02× | ◆ 21.73× | 72.47× | 27.26× | 27.26× +47% | |
| Market Cap | ₹15,119 Cr | ₹63,381 Cr | ₹2.49L Cr | ₹21,219 Cr | ₹63,381 Cr -76% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | ◆ 14.85% | 10.78% | 14.25% | 14.25% | |
| Revenue CAGR 5Y | — | ◆ 18.96% | 8.67% | 15.56% | 15.56% | |
| Net Income CAGR 3Y | — | -16.91% | 12.09% | ◆ 19.89% | 12.09% | |
| Revenue YoY (latest Q) | 26.23% | 10.00% | ◆ 27.80% | 19.63% | 19.63% +34% | |
| Net Income YoY (latest Q) | 30.96% | 53.36% | ◆ 65.50% | 18.79% | 53.36% -42% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 34.83% | 20.41% | 32.59% | 34.79% | 32.59% +7% | |
| Net Income Margin | 24.57% | 2.18% | 24.32% | ◆ 29.71% | 24.32% +1% | |
| Return on Common Equity | 12.95% | 1.05% | 15.32% | ◆ 17.66% | 15.32% -15% | |
| Return on Capital Employed | 14.18% | 3.02% | 16.55% | ◆ 18.80% | 16.55% -14% | |
| Return on Assets | 11.60% | 0.58% | 12.82% | ◆ 16.06% | 12.82% -10% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.00× | 0.40× | 0.00× | 0.00× | 0.00× | |
| Interest Coverage | ◆ 1034.40× | 1.51× | 129.48× | 790.90× | 129.48× +699% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹1,055 Cr | ₹16,927 Cr | ₹10,560 Cr | ₹2,187 Cr | ₹10,560 Cr -90% | |
| Net Income | ₹259 Cr | ₹369 Cr | ₹2,568 Cr | ₹650 Cr | ₹650 Cr -60% | |
| Total Assets | ₹2,235 Cr | ₹63,651 Cr | ₹20,033 Cr | ₹4,045 Cr | ₹20,033 Cr -89% | |
| EPS | ₹24.78 | ₹2.82 | ₹96.75 | ₹84.36 | ₹84.36 -71% | |
| Book Value per Share | ₹192.62 | ₹225.92 | ₹632.49 | ₹477.74 | ₹477.74 -60% | |